Status:
UNKNOWN
Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Diabetic Foot
Lower Limb Ischemia
Eligibility:
All Genders
30-78 years
Phase:
PHASE1
Brief Summary
Mesenchymal stem cells with multidirectional differentiation potential,autologous stem cell transplantation into ischemic foot, make its differentiation to form new blood capillary, improve and restor...
Eligibility Criteria
Inclusion
- the age of 30-78 years old, men and women there is no limit.
- in accordance with the ministry of health in higher medical colleges and universities teaching material the sixth edition of the annals of diabetic foot diagnostic criteria.
- with severe lower limb ischemia (defined as the resting state of ankle brachial index (ABI) 0.4-0.85, accompanied by resting or intermittent toe line.
- treatment on a voluntary basis, and sign the informed consent.
Exclusion
- with severe heart, liver, kidney, lung function failure or general condition is very poor can't tolerate the stem cell transplant.
- clear over the past five years tumor markers in patients with malignant disease and blood levels increased significantly.
- the prodrome of acute infectious diseases.
- participated in clinical subjects within three months before test.
- adherence is poor, can not complete the course.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02304588
Start Date
January 1 2013
End Date
December 1 2017
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100039